Advanced search
Publication Cover
Pharmacogenomics Volume 8, 2007 - Issue 3
Submit an article Journal homepage
482
Views
0
CrossRef citations to date
0
Altmetric
Review

Diagnostic Potential for Urinary Proteomics

Glen L Hortin1 National Institutes of Health, Departments of Laboratory Medicine, Warren Magnuson Clinical Center, Building 10, Room 2C-407, Bethesda, MD20892–1508, USA.Correspondence[email protected]
View further author information
&
Denis Sviridov1 National Institutes of Health, Departments of Laboratory Medicine, Warren Magnuson Clinical Center, Building 10, Room 2C-407, Bethesda, MD20892–1508, USA.View further author information
Pages 237-255 | Published online: 27 Feb 2007

Bibliography

  • Anderson NG , AndersonNL, TollaksenSL: Proteins of human urine. I. Concentration and analysis by two-dimensional electrophoresis.Clin. Chem.25 , 1199–1210 (1979).
  • Pieper R , GatlinCL, McGrathAM et al.: Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimension electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics4 , 1159–1174 (2004).
  • Oh J , PyoJH, JoEH et al.: Establishment of a near-standard two-dimensional human urine proteomic map. Proteomics4 , 3485–3497 (2004).
  • Castagna A , CecconiD, Sennels et al.: Exploring the hidden human urinary proteome via ligand library beads. J. Proteome Res.4 , 1917–1930 (2005).
  • Sun W , LiF, WuS et al.: Human urine proteome analysis by three separation approaches. Proteomics5 , 4994–5001 (2005).
  • Khan A , PackerNH: Simple urinary sample preparation for proteomics analysis.J. Proteome Res.5 , 2824–2838 (2006).
  • Zerefos PG , VougasK, DimitrakiP et al.: Characterization of the human urine proteome by preparative electophoresis in combination with 2-DE. Proteomics6 , 4346–4355 (2006).
  • Adachi J , KumarC, ZhangY, OlsenJV, MannM: The human urinary proteome contains more than 1500 proteins including a large proportion of membrane proteins.Genome Biol.7(R80) , 1–16 (2006).
  • Heine G , RaidaM, ForssmannWG: Mapping of peptides and protein fragments in human urine using liquid chromatography-mass spectrometry.J. Chromatog. A776 , 117–124 (1997).
  • Cutillas PR , NordenAG, CramerR et al.: Detection and analysis of urinary peptides by on-line liquid chromatography and mass spectrometry: application to patients with renal Fanconi syndrome. Clin. Sci. (Lond.)104 , 483–490 (2003).
  • Wittke S , MischakH, WaldenM, KolchW, RadlerT, WiedemannK: Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: towards new diagnostic and therapeutic approaches.Electrophoresis26 , 1476–1487 (2005).
  • Jurgens M , AppelA, HeineG et al.: Towards characterization of the human urinary peptidome. Comb. Chem. High Throughput Screening8 , 757–765 (2005).
  • Vlahou A , SchellhammerPF, MendrinosS et al.: Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am. J. Pathol.158 , 1491–1502 (2001).
  • Hampel DJ , SansomeC, ShaM et al.: Toward proteomics in uroscopy: urinary protein profiles after radiocontrast medium administration. J. Am. Soc. Nephrol.12 , 1026–1035 (2001).
  • Spahr CS , DavisMT, McGinleyMD et al.: Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. I. Profiling an unfractionated tryptic digest. Proteomics1 , 93–107 (2001).
  • Lafitte D , DussolB, AndersenS et al.: Optimized preparation of urine samples for two-dimensional electrophoresis and initial application to patient samples. Clin. Biochem.35 , 581–589 (2002).
  • Rehman I , AzzouziAR, CattoJW et al.: Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study. Urology64 , 1238–1243 (2004).
  • Schaub S , WilkinsJ, WeilerT et al.: Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int.65 , 323–332 (2004).
  • Van QN , KloseJR, LucasDA et al.: The use of urine proteomic and metabonomic patterns for the diagnosis of interstitial cystitis and bacterial cystitis. Dis. Markers19 , 169–183 (2003–2004).
  • Zhang YF , WuDL, GuanM et al.: Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient. Clin. Biochem.37 , 772–779 (2004).
  • Cutillas PR , ChalkleyRJ, HansenKC et al.: The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells. Am. J. Physiol. Renal Physiol.287 , F353–F364 (2004).
  • Hortin GL , MeilingerB, DrakeSK: Size-selective extraction of peptides from urine for mass spectrometric analysis.Clin. Chem.50 , 1092–1095 (2004).
  • Pisitkun T , ShenRF, KnepperMA: Identification and proteomic profiling of exosomes in human urine.Proc. Natl Acad. Sci.101 , 13368–13373 (2004).
  • Braun MC , LiL, KeB et al.: Proteomic profiling of urinary protein excretion in the factor H-deficient mouse. Am. J. Nephrol.26 , 127–135 (2006).
  • Ye B , SkatesS, MokSC et al.: Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine. Clin. Cancer Res.12 , 432–441 (2006).
  • Lin CY , TsuiKH, YuCC, YehCW, Chang PL, Yung BY: Searching cell-secreted proteomes for potential urinary bladder tumor markers. Proteomics6 , 4381–4389 (2006).
  • Park MR , WangEH, JinDC et al.: Establishment of a 2D human urinary proteomic map in IgA nephropathy. Proteomics6 , 1066–1076 (2006).
  • Krishna J , ShahZA, MerchantM, Klein JB, Gozal D: Urinary protein expression patterns in children with sleep-disordered breathing: preliminary findings. Sleep Med.7 , 221–227 (2006).
  • Khurana M , TraumAZ, AivadoM et al.: Urine proteomic profiling of pediatric nephritic syndrome. Pediatr. Nephrol.21 , 1257–1265 (2006).
  • Ngai HH , SitWH, JiangPP, XuRJ, Wan JM, Thongboonkerd V: Serial changes in urinary proteome profile of membranous nephropathy: implications for pathophysiology and biomarker discovery. J. Proteome Res.5 , 3038–3047 (2006).
  • Soldi M , SartoC, ValscchiC et al.: Proteome profile of human urine with two-dimensional liquid phase fractionation. Proteomics5 , 2641–2647 (2005).
  • Thongboonkerd V , ChutipongtanateS, KanlayaR: Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: quantity, quality, and variability.J. Proteome Res.5 , 183–191 (2006).
  • Traum AZ , WellsMP, AivadoM et al.: SELDI-TOF MS of quadruplicate urine and serum samples to evaluate changes related to storage conditions. Proteomics6 , 1676–1680 (2006).
  • Fiedler GM , BaumannS, LeichtleA et al.: Standardized peptidome profiling of human urine using magnetic-bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin. Chem. (2007) (In Press).
  • Ferguson RE , SelbyPJ, BanksRE: Proteomic studies in urological malignancies.Contrib. Nephrol.141 , 257–279 (2004).
  • Ransom RF : Podocyte proteomics.Contrib. Nephrol.141 , 189–211 (2004).
  • Witzmann FA , LiJ: Proteomics and nephrotoxicity.Contrib. Nephrol.141 , 104–123 (2004).
  • Chevalier RL : Obstructive nephropathy: towards biomarker discovery and gene therapy.Nat. Clin. Prac. Nephrol.2 , 157–168 (2005).
  • Thongboonkerd V , MalasitP: Renal and urinary proteomics: current applications and challenges.Proteomics5 , 1033–1042 (2005).
  • Merchant ML , KleinJB: Proteomics and diabetic nephropathy.Curr. Diab. Rep.5 , 464–469 (2005).
  • Pisitkun T , JohnstoneR, KnepperMA: Discovery of urinary biomarkers.Mol. Cell. Proteomics5 , 1760–1771 (2006).
  • Downes MR , ByrneJC, DunnMJ, FitzpatrickJM, WatsonRW, Pennington SR: Application of proteomic strategies to the identification of urinary biomarkers for prostate cancer: a review. Biomarkers11 , 406–416 (2006).
  • O‘Riordan E , GrossSS, GoligorskyMS: Technology insight: Renal proteomics – at the crossroads between promise and problems.Nat. Clin. Pract. Nephrol.2 , 445–458 (2006).
  • Hoorn EJ , HoffertJD, KnepperMA: The application of DIGE-based proteomics to renal physiology.Nephron Physiol.104 , 61–72 (2006).
  • Gonzalez-Buitrago JM , FerreiraL, Lorenzo I: Urinary proteomics. Clin. Chim. Acta375 , 49–56 (2007).
  • Voswinckel P : From uroscopy to urinalysis.Clin. Chim. Acta297 , 5–16 (2000).
  • Bright R : Cases and observations illustrative of renal disease accompanied with the secretion of albuminous urine.Guy‘s Hosp. Rep.1 , 338–379 (1836).
  • Bence Jones H : On a new substance occurring in the urine of a patient with mollities ossium.Philos. Trans. R. Soc. London138 , 55–62 (1848).
  • Simerville JA , MaxtedWC, PahiraJJ: Urinalysis: a comprehensive review.Am. Fam. Physician74 , 1153–1162 (2005).
  • Johnson CA , LeveyAS, CoreshJ et al.: Clinical practice guidelines for chronic kidney disease in adults: Part II. Glomerular filtration rate, proteinuria, and other markers. Am. Fam. Physician70 , 1091–1097 (2004).
  • Viberti GC , HillRD, JarrettRJ et al.: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet1430–1432 (1982).
  • Arnlov J , EvansJC, MeigsJB et al.: Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation112 , 969–975 (2005).
  • Sarafidis PA , KhoslaN, BakrisGL: Antihypertensive therapy in the presence of proteinuria.Am. J. Kidney Dis.49 , 12–26 (2007).
  • Guder WG , IvandicM, HofmannW: Physiopathology of proteinuria and laboratory diagnostic strategy based on single protein analysis.Clin. Chem. Lab. Med.36 , 935–939 (1998).
  • Tencer J , BakoushO, TorffvitO: Diagnostic and prognostic significance of proteinuria selectivity index in glomerular diseases.Clin. Chim. Acta297 , 73–83 (2000).
  • Maachi M , FellahiS, RegeniterA et al.: Patterns of proteinuria: urinary sodium dodecyl sulfate electrophoresis versus immunonephelometric protein marker measurement followed by interpretation with the knowledge-based system MDI-LabLink. Clin. Chem.50 , 1834–1837 (2004).
  • Kuzniar J , MarchewkaZ, KrasnowskiR et al.: Enzymuria and low-molecular-weight protein excretion as the differentiating marker of complications in the early post kidney transplantation period. Int. Urol. Nephrol. (2006) (Epub ahead of print).
  • Oetting WS , RogersTB, KrickTP, Matas AJ, Ibrahim HN: Urinary β2-microglobulin is associated with acute renal allograft rejection. Am. J. Kidney Dis.47 , 898–904 (2006).
  • Unay B , AkinR, SariciSU et al.: Evaluation of renal tubular function in children taking anti-epileptic treatment. Nephrology11 , 485–488 (2006).
  • Kobayashi E , SuwazonoY, UetaniM et al.: Estimation of the benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, β2-microglobulin, and N-acetyl-β-d-glucosaminidase in cadmium nonpolluted regions in Japan. Environ. Res.101 , 401–406 (2006).
  • Voskaridou E , TerposE, MichailS et al.: Early markers of renal dysfunction in patients with sickle cell/β-thalassemia. Kidney Int.69 , 2037–2042 (2006).
  • Herget-Rosenthal S , PoppenD, HusingJ et al.: Prognostic value of tubular proteinuria and enymuria in nonoliguric acute tubular necrosis. Clin. Chem.50 , 552–558 (2004).
  • Herget-Rosenthal S , FeldkampT, Volbracht L, Kribben A: Measurement of urinary cystatin C by particle-enhanced nephelometric immunoassay: precision, interferences, stability and reference range. Ann. Clin. Biochem.41 , 111–118 (2004).
  • Nakano T , NagataA, TakahashiH: Ratio of urinary free immunoglobulin light chain κ to λ in the diagnosis of Bence Jones proteinuria.Clin. Chem. Lab. Med.42 , 429–434 (2004).
  • Cole LA , KhanlianSA, SuttonJM, Davies S, Stephens ND: Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection. Clin. Biochem.36 , 647–655 (2003).
  • Khattab AF , MustafaFA, TaylorPJ: The use of LH detection kits to time intrauterine insemination with donor sperm.Hum. Reprod.20 , 2542–2545 (2005).
  • van Rhijn BW , van der Poel HG, van der Kwast TH: Urine markers for bladder cancer suveillance: a systematic review. Eur. Urol.47 , 736–748 (2005).
  • Pagani F , FrancucciCM, MoroL: Markers of bone turnover: biochemical and clinical perspectives.J. Endocrinol. Invest.28(Suppl. 10) , 8–13 (2005).
  • Ivaska KK , KakonnenSM, GerdhemP et al.: Urinary osteocalcin as a marker of bone metabolism. Clin. Chem.51 , 618–628 (2005).
  • Buyken AE , KellerhoffY, HahnS, KrokeA, RemerT: Urinary C-peptide excretion in free-living healthy children is related to dietary carbohydrate intake but not to the dietary glycemic index.J. Nutr.136 , 1828–1833 (2006).
  • Jang T , UzbieloA, SineffS et al.: Point-of-care urine trypsinogen testing for the diagnosis of pancreatitis. Acad. Emerg. Med.14 , 29–34 (2007).
  • David WS : Myoglobinuria.Neurol. Clin.18 , 215–243 (2000).
  • Desai S , BatesH, MichalskiFJ: Detection of antibody to HIV-1 in urine.Lancet337 , 183–184 (1991).
  • Muhsen K , AthamnaA, AthamnaM, Spungin-BialikA, CohenD: Evaluation of a urine-based enzyme-linked immunosorbent assay test for the detection of Helicobacter pylori infection among 3- to 5-year-old Israeli Arab healthy children.Pediatr. Gastroenterol. Nutr.43 , 398–401 (2006).
  • Diederen BM , PeetersMF: Evaluation of two new immunochromatographic assays (Rapid U Legionella antigen test and SD Bioline Legionella antigen test) for detection of Legionella pneumophila serogroup 1 antigen in urine.J. Clin. Microbiol.44 , 2991–2993 (2006).
  • Cruz I , ChicharroC, NietoJ et al.: Comparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasis. J. Clin. Microbiol.44 , 2343–2347 (2006).
  • Stothard JR , KabatereineNB, Tukahebw EM et al.: Use of circulating cathodic antigen (CCA) dipsticks for detection of intestinal and urinary schistosomiasis. Acta Trop.97 , 219–228 (2006).
  • Matz M , BeyerJ, WunschD et al.: Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function. Kidney Int.69 , 1683–1690 (2006).
  • Hauser IA , SpieglerS, KissE et al.: Prediction of acute renal allograft rejection by urinary monokine induced by IFN-γ (MIG). J. Am Soc. Nephrol.16 , 1849–1858 (2005).
  • Pugia MJ , LottJA: Pathophysiology and diagnostic value of urinary trypsin inhibitors.Clin. Chem. Lab. Med.43 , 1–16 (2005).
  • Pugia MJ , JortaniSA, BasuM et al.: Immunological evaluation of urinary trypsin inhibitors in blood and urine: role of N- and O-linked glycoproteins. Glyconjug. J.24 , 5–15 (2007).
  • Ichimura T , HungCC, YangSA, StevensJL, BonventreJV: Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury.Am. J. Renal Physiol.286 , F552–F563 (2004).
  • Kamijo-Ikemori A , SugayaT, KimuraK: Urinary fatty acid binding protein in renal disease.Clin. Chim. Acta374 , 1–7 (2006).
  • Chen L , JinT, HuangB et al.: Critical exposure level of cadmium for elevated urinary metallothionein – an occupation population study in China. Toxicol. Appl. Pharmacol.215 , 93–99 (2006).
  • Lind SE , GoldshteynS, BarryCP et al.: Assessment of coagulation system activation using spot urine measurements. Blood Coagul. Fibrinolysis10 , 285–289 (1999).
  • Morris TA , MarshJJ, BurrowsCM et al.: Urine and plasma levels of fibrinopeptide B in patients with deep vein thrombosis and pulmonary embolism. Thromb. Res.110 , 159–165 (2003).
  • Yoshikawa R , WadaJ, SeikiK et al.: Urinary PGDS levels are associated with vascular injury in type 2 diabetes patients. Diabetes Res. Clin. Practice (2006) (In Press).
  • Papanikolaou G , TzilianosM, ChristakisJI et al.: Hepcidin in iron overload disorders. Blood105 , 4103–4105 (2005).
  • Kearney SL , NemethE, NeufeldEJ et al.: Urinary hepcidin in congenital chronic anemias. Pediatr. Blood Cancer48 , 57–63 (2007).
  • Magid E , GuldagerH, HesseD, ChristiansenMS: Monitoring urinary orosomucoid in acute inflammation: observations on urinary excretion of orosomucoid, albumin, α1-microglobulin, and IgG.Clin. Chem.51 , 2052–2058 (2005).
  • Ecke TH , SchlechteHH, SchulzeG, Lenk SV, Loening SA: Four tumour makers for urinary bladder cancer – tissue polypeptide antigen (TPA), HER-2/neu (ERB B2), urokinase-type plasminogen activator receptor (uPAR) and TP53 mutation. Anticancer Res.25 , 635–641 (2005).
  • di Carlo A , TerraccianoD, MarianoA, MacchiaV: Urinary gelatinase activities (matrix metalloproteinases 2 and 9) in human bladder tumors.Oncol. Rep.15 , 1321–1326 (2006).
  • Wagener G , JanM, KimM et al.: Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology105 , 485–491 (2006).
  • Parikh CR , JaniA, MishraJ et al.: Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am. J. Transplant.6 , 1639–1645 (2006).
  • Hutchinson LM , ChangEL, BeckerCM et al.: Use of thymosin β15 as a urinary biomarker in human prostate cancer. Prostate64 , 116–127 (2005).
  • Helantera I , TeppoAM, KoskinenP et al.: Increased urinary excretion of transforming growth factor-β(1) in renal transplant recipients with cytomegalovirus infection. Transpl. Immunol.15 , 217–221 (2006).
  • Li Y , TucciM, NarainS et al.: Urinary biomarkers in lupus nephritis. Autoimmun. Rev.5 , 383–388 (2006).
  • Moore CK , GoldmanHB: The bladder epithelium and overactive bladder: what we know.Curr. Urol. Rep.7 , 447–449 (2006).
  • Lamale LM , LutgendorfSK, Zimmerman MB, Kreder KJ: Interleukin-6, histamine, and methylhistamine as diagnostic markers for interstitial cystitis. Urology68 , 702–706 (2006).
  • Zager RA , JohnsonAC, HansonSY, Lund S: Acute nephrotoxic and obstructive injury primes the kidney to endotoxin-driven cytokine/chemokine production. Kidney Int.69 , 1181–1188 (2006).
  • Ciszek M , PaczekL, BartiomiejczykI, MuchaK: Urine cytokines profile in renal transplant patients with asymptomatic bacteriuria.Transplantation81 , 1653–1657 (2006).
  • Schaub S , WilkinsJA, AntonoviciM et al.: Proteomic-based identification of cleaved urinary β2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am. J. Transplant.5 , 729–738 (2005).
  • Zhou H , PisitkunT, AponteA et al.: Exosomal fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int.70 , 1847–1857 (2006).
  • Liu BC , ZhangL, LuLL et al.: Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease. Am. J. Nephrol.26 , 483–490 (2006).
  • Norden AGW , SharrattP, CutillasPR et al.: Quantitative amino acid and proteomic analysis: very low excretion of polypeptides > 750 Da in normal urine. Kidney Int.66 , 1994–2003 (2004).
  • Hortin GL , MeilingerB: Cross-reactivity of amino acids and other compounds in the biuret reaction: interference with urinary peptide measurements.Clin. Chem.51 , 1411–1419 (2005).
  • Strong KJ , OsickaTM, ComperWD: Urinary-peptide excretion by patients with and volunteers without diabetes.J. Lab. Clin. Med.145 , 239–246 (2005).
  • Hortin GL : The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome.Clin. Chem.52 , 1223–1237 (2006).
  • Lou MF , HamiltonPB: Separation and quantitation of peptides and amino acids in normal human urine.Meth. Biochem. Anal.25 , 203–271 (1979).
  • Osicka TM , ComperWD: Characterization of immunochemically nonreactive urinary albumin.Clin. Chem.50 , 2286–2291 (2004).
  • Owen WE , RobertsWL: Performance characteristics of an HPLC assay for urinary albumin.Am. J. Clin. Pathol.124 , 219–225 (2005).
  • Polkinghorne KR , SuQ, ChadbanSJ et al.: Population prevalence of albuminuria in the Australian diabetes, obesity, and lifestyle (AusDiab) study: immunonephelometry compared with high-performance liquid chromatography. Am. J. Kidney Dis.47 , 604–613 (2006).
  • Sviridov D , MeilingerB, DrakeSK, Hoehn GT, Hortin GL: Co-elution of other proteins with albumin during size-exclusion hplc: implications for urine albumin analysis. Clin. Chem.252 , 389–397 (2006).
  • Peters T : How should we measure albumin in urine?Clin. Chem.52 , 555–556 (2006).
  • Candiano G , MusanteL, BruschiM et al.: Repetitive fragmentation products of albumin and α1-antitrypsin in glomerular diseases associated with nephritic syndrome. J. Am. Soc. Nephrol.17 , 3139–3148 (2006).
  • Brenner BM , HostetterTH, HumesHD: Molecular basis of proteinuria of glomerular origin.N. Engl. J. Med.298 , 826–833 (1978).
  • Norden AGW , LapsleyM, LeePJ et al.: Glomerular protein sieving and implications for renal failure in Fanconi syndrome. Kidney Int.60 , 1885–1892 (2001).
  • Deen WM : What determines glomerular capillary permeability?J. Clin. Invest.114 , 1412–1414 (2004).
  • Vanholder R , De Smet R, Glorieux G et al.: Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int.63 , 1934–1943 (2003).
  • Harris JM , ChessRB: Effect of pegylation on pharmaceuticals.Nat. Rev. Drug Discov.2 , 214–221 (2003).
  • Zobel K , KoehlerMF, BeresiniMH, Caris LD, Combs D: Phosphate ester serum albumin affinity tags greatly improve peptide half-life in vivo. Bioorg. Med. Chem. Lett.12 , 2883–2886 (2002).
  • Christensen EI , GburekJ: Protein reabsorption in renal proximal tubule-function and dysfunction in kidney pathophysiology.Pediatr. Nephrol.19 , 714–721 (2004).
  • Gekle M : Renal tubule albumin transport.Annu. Rev. Physiol.67 , 573–594 (2005).
  • Negri AL : Proximal tubule endocytic apparatus as the specific renal uptake mechanism for vitamin D-binding protein/25-(OH)D3 complex.Nephrology11 , 510–515 (2006).
  • Bond JS , MattersGL, BanerjeeS, Dusheck RE: Meprin metalloprotease expression and regulation in kidney, intestine, urinary tract infections and cancer. FEBS Let.579 , 3317–3322 (2005).
  • Trof RJ , Di Maggio F, Leemreis J, Groeneveld AB: Biomarkers of acute renal injury and renal failure. Shock26 , 245–253 (2006).
  • El-Achkar TM , DagherPC: Renal toll-like receptors: recent advances and implications for disease.Nat. Clin. Prac. Nephrol.2 , 568–581 (2006).
  • Mak RH , KuoHJ: Pathogenesis of urinary tract infection: an update.Curr. Opin. Pediatr.18 , 148–152 (2006).
  • Serafini-Cessi F , MalagoliniN, CavalloneD: Tamm–Horsfall glycoprotein: biology and clinical relevance.Am. J. Kidney Dis.42 , 658–676 (2003).
  • Melegos DN , DiamandisEP, OdaH, Urade Y, Hayaishi O: Immunofluorometric assay of prostaglandin D synthase in human tissue extracts and fluids. Clin. Chem.42 , 1984–1991 (1996).
  • Oda H , ShiinaY, SeikiK et al.: Development and evaluation of a practical ELISA for human urinary lipocalin-type prostaglandin D synthase. Clin. Chem.48 , 1445–1453 (2002).
  • Mayo Medical Laboratories: 2006 Test Catalog. MML, Rochester, MN, USA (2006).
  • Bradwell AR : Serum Light Chain Analysis (2nd Edition). The Binding Site, Ltd, Birmingham, UK (2004).
  • Narita T , SasakiH, HosobaM et al.: Parallel increase in urinary excretion rates of immunoglobulin G, ceruloplasmin, transferrin, and orosomucoid in normoalbuminuric Type 2 diabetic patients. Diabetes Care27 , 1176–1181 (2004).
  • Penders J , DelangheJR: α1-microglobulin: clinical laboratory aspects and applications.Clin. Chim. Acta346 , 107–118 (2004).
  • Lauridsen AL , AarupM, ChristensenAL et al.: Sensitive automated ELISA for measurement of vitamin D-binding protein (Gc) in human urine. Clin. Chem.51 , 1016–1018 (2005).
  • Tencer J Thysell H, Andersson K, Grubb A: Long-term stability of albumin, protein HC, immunoglobulin G, κ- and λ-chain-immunoreactivity, orosomucoid, and a1-antitrypsin in urine stored at -20 degrees C. Scand. J. Urol. Nephrol.31 , 67–71 (1997).
  • Maslamani S , GlentonPA, KhanSR: Changes in urine macromolecular composition during processing.J. Urol.164 , 230–236 (2000).
  • Senturk UK , KuruO, KocerG, GunduzF: Biphasic pattern of exercise-induced proteinuria in sedentary and trained men.Nephron Physiol.105 , 22–32 (2007).
  • Groskopf J , AubinSM, DerasIL et al.: APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. Clin. Chem.52 , 1089–1095 (2006).
  • Domachevsky L , GrupperM, ShochatT, AdirY: Proteinuria on dipstick urine analysis after sexual intercourse.BJU Int.97 , 146–148 (2006).
  • Atmani F , KhanSR: Quantification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in vitro in the urine of healthy controls and stone-forming patients.Urol. Int.68 , 54–59 (2002).
  • Finkel E : Cloudy or clear? Best forecasts for urine cultures.CAP Today20(11) , 86–90 (2006).
  • Lifshitz E , KramerL: Outpatient urine culture: does collection technique matter?Arch. Intern. Med.160 , 2537–2540 (2000).
  • Bakker AJ : Immunoturbidimetry of urinary albumin: prevention of adsorption of albumin; influence of other urinary constituents.Clin. Chem.34 , 82–86 (1988).
  • Brinkman JW , de Zeeuw D, Duker JJ et al.: Falsely low urinary albumin concentrations after prolonged frozen storage of urine samples. Clin. Chem.51 , 2181–2183 (2005).
  • Cantin GT , YatesJR 3rd: Strategies for shotgun identification of post-translational modifications by mass spectrometry. J. Chromatogr A1053 , 7–14 (2004).
  • Bogdanov B , SmithRD: Proteomics by FTICR mass spectrometry: top down and bottom up.Mass Spectrom. Rev.24 , 168–200 (2005).
  • Hortin GL , JortaniSA, RitchieJC et al.: Proteomics: a new diagnostic frontier. Clin. Chem.52 , 1218–1222 (2006).
  • Domon B , AebersoldR: Mass spectrometry and protein analysis.Science312 , 212–217 (2006).
  • van der Merwe DE , OikonomopoulouK, MarshallJ, DiamandisEP: Mass spectrometry: uncovering the cancer proteome for diagnostics.Adv. Cancer Res.96 , 23–50 (2007).
  • Julka S , RegnierF: Quantification in proteomics through stable isotope coding: a review.J. Proteome Res.3 , 350–363 (2004).
  • Wu WW , WangG, BaekSJ, ShenRF: Comparative study of three proteomic quantitative methods, DIGE, cICAT, and ITRAQ, using 2D gel- or LC-MALDI TOF/TOF.J. Proteome Res.5 , 651–658 (2006).
  • Hortin GL : Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice?Clin. Chem.51 , 3–5 (2005).
  • Anderson L , HunterCL: Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins.Mol. Cell. Proteomics5 , 573–588 (2006).
  • Fierens C , StocklD, BaetensD, Leenheer AP, Thienpont LM: Standardization of C-peptide measurements in urine by method comparison with isotope-dilution mass spectrometry. Clin. Chem.49 , 992–994 (2003).
  • Babic N , LarsonTS, GrebeSK, TurnerST, KumarR, SinghRJ: Application of liquid chromatography-mass spectrometry technology for early detection of microalbuminuria in patients with kidney disease.Clin. Chem.52 , 2155–2157 (2006).
  • Luo Y , ChenM, WenQ et al.: Rapid and simultaneous quantification of 4 urinary proteins by piezoelectric quartz crystal microbalance immunosensor array. Clin. Chem.52 , 2273–2280 (2006).
  • Kricka LJ , MasterSR, JoosTO, FortinaP: Current perspectives in protein array technology.Ann. Clin. Biochem.43 , 457–467 (2006).
  • Xiao Z , AdamBL, CazaresLH et al.: Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. Cancer Res.61 , 6029–6033 (2001).
  • Nedelkov D , KiernanUA, NiederkoflerEE, Tubbs,KA, NelsonRW: Investigating diversity in human plasma proteins.Proc. Natl Acad. Sci.102 , 10852–10857 (2005).
  • Petricoin EF , BellucoC, AraujoRP, Liotta LA: The blood peptidome: a higher dimension of information content for cancer biomarker discovery. Nat. Rev. Cancer6 , 961–967 (2006).
  • Lopez MF , MikulskisA, KuzdzalS et al.: High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures. Clin. Chem.51 , 1946–1954 (2005).
  • Boguski MS , McIntoshMW: Biomedical informatics for proteomics.Nature422 , 233–237 (2003).
  • Palagi PM , HernandezP, WaltherD, Appel RD: Proteome informatics I: bioinformatics tools for processing experimental data. Proteomics6 , 5435–5444 (2006).
  • States DJ , OmennGS, BlackwellTW et al.: Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat. Biotechnol.24 , 333–338 (2006).
  • Ransohoff DF : Bias as a threat to the validity of cancer molecular-marker research.Nat. Rev. Cancer5 , 142–149 (2005).
  • Vitzthum F , BehrensF, AndersonNL, Shaw JH: Proteomics for basic research to diagnostic application. A review of requirements and needs. J. Proteome Res.4 , 1086–1097 (2005).
  • Master SR : Diagnostic proteomics: back to basics?Clin. Chem.51 , 1333–1334 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.